Results 201 to 210 of about 621,434 (269)

Chemoimmunotherapy‐associated CD20 (MS4A1) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

HemaSphere, Volume 10, Issue 10, October 2026.
Alberto Guijosa, Nickolas Tsakmaklis, Sirano Dhe‐Paganon, Filip Garbicz, Ruben Carrasco, John Hatcher, Andres Ramirez‐Gamero, Dominic Pizzarella, Amanda Kofides, Shirong Liu, Hao Sun, Xia Liu, María L. Guerrera, Andrew R. Branagan, Gottfried von Keudell, Shayna R. Sarosiek, Jorge J. Castillo, Zachary R. Hunter, Steven P. Treon   +18 more
wiley   +1 more source

IgM promotes antitumor immunity to a Tn-expressing solid tumor. [PDF]

J Immunother Cancer
Nzuki HL, Jennings-Gee JE, Trivette M, Mosher TH, Adams-Sims AE, Hegarty AA, Haas KM.   +6 more
europepmc   +1 more source

A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity. [PDF]

Angew Chem Int Ed Engl, 2014
Richichi B, Thomas B, Fiore M, Bosco R, Qureshi H, Nativi C, Renaudet O, BenMohamed L.   +7 more
europepmc   +1 more source

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance. [PDF]

Cancer Immunol Res
King-Peoples TR, Keane JT, Lewis HS, Liu F, Brookens SK, Dagher OK, Parvathaneni K, Gardner BL, Ahmed A, Furth EE, Lal P, Posey AD.   +11 more
europepmc   +1 more source

Design of Therapeutic Vaccines Based on the Tn Antigen

Esta tesis se centra en el diseño racional y la evaluación de vacunas contra el cáncer basadas en glicopéptidos no naturales derivados de MUC1 que incorporan el antígeno Tn en posiciones estratégicas de la secuencia peptídica. Aunque estos glicopéptidos presentan un alto potencial como vacunas contra el cáncer, las formulaciones basadas en MUC1 suelen ...
openaire   +1 more source

Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody. [PDF]

Angew Chem Int Ed Engl, 2015
Martínez-Sáez N, Castro-López J, Valero-González J, Madariaga D, Compañón I, Somovilla VJ, Salvadó M, Asensio JL, Jiménez-Barbero J, Avenoza A, Busto JH, Bernardes GJ, Peregrina JM, Hurtado-Guerrero R, Corzana F.   +14 more
europepmc   +1 more source

From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer. [PDF]

Chem Rev
Aasted MKM, Jaroentomeechai T, Dabelsteen S, Joshi H, Stowell SR, Wandall HH.   +5 more
europepmc   +1 more source

A Chemically Defined Four-Component Self-Adjuvanting Tn Vaccine Activating Mincle, FcγR, and CD206 for Enhanced Antitumor Immunity. [PDF]

Adv Sci (Weinh)
Ming W, Zhang R, Li X, Li G, Niu Y, Yang D, Luo X, Liao J, Liu Z, Liao G.   +9 more
europepmc   +1 more source

MUC1 glycopeptides incorporating Tn antigen mimetics

, 2023
C. Breton [0000-0002-3531-6676], M. Torres [0009-0007-0057-0176], P. Oroz, I. Compañón, A. Avenoza [0000-0002-5465-3555], M. M. Zurbano [0000-0001-6370-3537], J. H. Busto [0000-0003-4403-4790], F. Corzana [0000-0001-5597-8127], J. M. Peregrina [0000-0003-3778-7065]   +8 more
openaire   +2 more sources